Pharmacovigilance is crucial in Taiwan’s drug registration to ensure ongoing safety monitoring after market approval. It involves tracking adverse events, submitting Periodic Safety Update Reports (PSURs), and updating drug labels as new risks emerge. The TFDA’s pharmacovigilance system ensures public health protection through proactive monitoring and compliance with safety regulations.
